Gongwin Biopharm Holdings Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 248,000 compared to TWD 0 a year ago. Operating loss was TWD 51.095 million compared to TWD 52.474 million a year ago. Net loss was TWD 42.859 million compared to TWD 48.922 million a year ago. Basic loss per share was TWD 0.42 compared to TWD 0.49 a year ago.